Biomanufacturing in Gene and Cell Therapy

Overview

Journal Mol Ther Methods Clin Dev

Publisher Cell Press

Date 2024 Jun 7

PMID 38846336

Authors

Daniel Stone

Xiuyang Wang

Mohamed Abou-El-Enein

Affiliations

Soon will be listed here.

References

Yonezawa Ogusuku I, Herbel V, Lennartz S, Brandes C, Argiro E, Fabian C . Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy. Mol Ther Methods Clin Dev. 2024; 32(2):101224. PMC: 10950868. DOI: 10.1016/j.omtm.2024.101224. View

Blay E, Hardyman E, Morovic W . PCR-based analytics of gene therapies using adeno-associated virus vectors: Considerations for cGMP method development. Mol Ther Methods Clin Dev. 2023; 31:101132. PMC: 10641278. DOI: 10.1016/j.omtm.2023.101132. View

Abou-El-Enein M, Elsallab M, Feldman S, Fesnak A, Heslop H, Marks P . Scalable Manufacturing of CAR T cells for Cancer Immunotherapy. Blood Cancer Discov. 2021; 2(5):408-422. PMC: 8462122. DOI: 10.1158/2643-3230.BCD-21-0084. View

Dias J, Garcia J, Agliardi G, Roddie C . CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development. Mol Ther Methods Clin Dev. 2024; 32(2):101250. PMC: 11088187. DOI: 10.1016/j.omtm.2024.101250. View

Mevel M, Pichard V, Bouzelha M, Alvarez-Dorta D, Lalys P, Provost N . Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency. Mol Ther Methods Clin Dev. 2024; 32(1):101187. PMC: 10847035. DOI: 10.1016/j.omtm.2024.101187. View

Cappabianca D, Pham D, Forsberg M, Bugel M, Tommasi A, Lauer A . Metabolic priming of GD2 -CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence. Mol Ther Methods Clin Dev. 2024; 32(2):101249. PMC: 11063605. DOI: 10.1016/j.omtm.2024.101249. View

Heckel J, Martinez A, Elger C, Haindl M, Leiss M, Ruppert R . Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors. Mol Ther Methods Clin Dev. 2023; 31:101148. PMC: 10690635. DOI: 10.1016/j.omtm.2023.101148. View

Mietzsch M, Liu W, Ma K, Bennett A, Nelson A, Gliwa K . Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard. Mol Ther Methods Clin Dev. 2023; 29:460-472. PMC: 10238842. DOI: 10.1016/j.omtm.2023.05.002. View

Stibbs D, Couto P, Takeuchi Y, Rafiq Q, Jackson N, Rayat A . Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor. Mol Ther Methods Clin Dev. 2024; 32(1):101209. PMC: 10907162. DOI: 10.1016/j.omtm.2024.101209. View

10.

Lydeard J, Lin M, Ge H, Halfond A, Wang S, Jones M . Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity. Mol Ther Methods Clin Dev. 2023; 31:101135. PMC: 10643325. DOI: 10.1016/j.omtm.2023.101135. View

11.

Kitte R, Rabel M, Geczy R, Park S, Fricke S, Koehl U . Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering. Mol Ther Methods Clin Dev. 2023; 31:101139. PMC: 10663670. DOI: 10.1016/j.omtm.2023.101139. View

12.

Malach P, Kay C, Tinworth C, Patel F, Joosse B, Wade J . Identification of a small molecule for enhancing lentiviral transduction of T cells. Mol Ther Methods Clin Dev. 2023; 31:101113. PMC: 10544093. DOI: 10.1016/j.omtm.2023.101113. View

13.

Braun M, Lange C, Schatz P, Long B, Stanta J, Gorovits B . Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements. Mol Ther Methods Clin Dev. 2024; 32(1):101217. PMC: 10944107. DOI: 10.1016/j.omtm.2024.101217. View

14.

Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack M, Wulffraat N, Leboulch P . LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003; 302(5644):415-9. DOI: 10.1126/science.1088547. View

15.

Poletti V, Montepeloso A, Pellin D, Biffi A . Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells. Mol Ther Methods Clin Dev. 2023; 31:101131. PMC: 10618226. DOI: 10.1016/j.omtm.2023.101131. View

16.

Rodgers B, Herring S, Carias D, Chen J, Rocha A . Development and validation of a model gene therapy biodistribution assay for AVGN7 using digital droplet polymerase chain reaction. Mol Ther Methods Clin Dev. 2023; 29:494-503. PMC: 10236005. DOI: 10.1016/j.omtm.2023.05.007. View

17.

Song H, Benzaoui M, Dwivedi A, Underwood S, Shao L, Achar S . Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output. Mol Ther Methods Clin Dev. 2024; 32(1):101171. PMC: 10827561. DOI: 10.1016/j.omtm.2023.101171. View

18.

Abou-El-Enein M, Angelis A, Appelbaum F, Andrews N, Bates S, Bierman A . Evidence generation and reproducibility in cell and gene therapy research: A call to action. Mol Ther Methods Clin Dev. 2021; 22:11-14. PMC: 8322039. DOI: 10.1016/j.omtm.2021.06.012. View

19.

Bastone A, Dziadek V, John-Neek P, Mansel F, Fleischauer J, Agyeman-Duah E . Development of an genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants. Mol Ther Methods Clin Dev. 2023; 30:515-533. PMC: 10491817. DOI: 10.1016/j.omtm.2023.08.017. View

20.

Marwidi Y, Nguyen H, Santos D, Wangzor T, Bhardwaj S, Ernie G . A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency. Mol Ther Methods Clin Dev. 2024; 32(2):101228. PMC: 10959708. DOI: 10.1016/j.omtm.2024.101228. View